XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Balance Sheets - USD ($)
Oct. 31, 2024
Apr. 30, 2024
Current Assets:    
Cash and cash equivalents $ 1,642,969 $ 229,705
Investment, at cost 16,500,000 16,500,000
Accounts receivable, net 87,256 273,874
Inventories, net 1,166,996 1,609,196
Prepaid inventory 810,978
Prepaid expenses and other current assets 185,540 197,871
Total Current Assets 19,582,761 19,621,624
Non-Current Assets:    
Note receivable - former subsidiary 2,000,000 2,000,000
Intangible assets, net of amortization 1,000 1,000
Total Non-Current Assets 2,001,000 2,001,000
TOTAL ASSETS 21,583,761 21,622,624
Current Liabilities:    
Accounts payable 4,597,403 4,704,596
Accrued expenses 4,419,304 3,405,372
Derivative liabilities 365 5,433
Other current liabilities 303,581 255,648
Total Current Liabilities 13,542,980 12,022,810
Total Liabilities 13,542,980 12,022,810
Commitments and contingency
SHAREHOLDERS’ EQUITY    
Common stock, par value, $0.001, 1,000,000,000 and 300,000,000 shares authorized, 6,435,454 and 1,828,541 shares issued and outstanding as of October 31, 2024 and April 30, 2024, respectively 6,435 1,828
Additional paid in capital 180,917,679 176,801,473
Accumulated deficit (172,973,917) (167,387,028)
Accumulated other comprehensive income 90,584 183,541
Total Stockholders’ Equity 8,040,781 9,599,814
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY 21,583,761 21,622,624
Nonrelated Party [Member]    
Current Liabilities:    
Accrued interest 643,234
Current portion of notes payable 1,491,845 1,564,513
Related Party [Member]    
Current Liabilities:    
Accrued interest 917,957 917,957
Current portion of notes payable $ 1,169,291 $ 1,169,291